Antibodies binding to the surface spike proteins of SARS-CoV-2 (IMAGE)
Caption
Illustration of antibodies binding to the surface spike proteins of SARS-CoV-2, the virus that causes COVID-19, blocking it from entering a person’s cells. A new Johns Hopkins Medicine study shows pediatric organ transplant recipients have higher levels of these antibodies after two doses of a COVID vaccine than their adult counterparts.
Credit
Courtesy of Lisa Donohue, COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Usage Restrictions
No restrictions.
License
Public Domain